Recent Finacing
Recent Raise
Clyde Biosciences develops the CellOPTIQ optical action-potential assay using iPSC-derived cardiomyocytes, voltage-sensitive dyes, and proprietary software to measure and analyze drug-induced cardiotoxicity on tissue-culture plates.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
